<DOC>
	<DOCNO>NCT01433757</DOCNO>
	<brief_summary>The purpose study evaluate antibiotic Ampicillin safe tolerate patient generalize dystonia cause DYT-1 gene mutation , compare patient treat placebo . A placebo pill look taste real drug , without active ingredient . The second objective study determine dystonia symptom improve study drug .</brief_summary>
	<brief_title>Ampicillin DYT-1 Dystonia Motor Symptoms</brief_title>
	<detailed_description>This double-blinded randomized drug study : neither patient investigator know patient take study drug ( Ampicillin ) placebo . Three study visit include neurological exam , review medical history , genetic test result video-taped BFM-DRS motor scale . Patients receive medication baseline visit , consist either Ampicillin drug placebo , consume twice daily 28 day . Following washout period ( drug ) 7 day , patient return clinic second study visit receive second set medication ( placebo -vs- Ampicillin ) . Medication consume twice daily 28 day , patient return clinic washout period 7 day final study visit clinic .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<criteria>DYT1 dystonia , confirm genetic testing Between age 7 80 year BFMDRS score great 6 Negative DYT1 dystonia gene test Allergy penicillins cephalosporin Concurrent bacterial , viral fungal infection time enrollment Pregnancy Inability follow study protocol Lactose intolerance ( placebo contain lactose powder )</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>dystonia</keyword>
	<keyword>DYT-1</keyword>
	<keyword>AMPICILLIN</keyword>
</DOC>